Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT03029793
Eligibility Criteria:
Inclusion Criteria:
1. Patient must have histologic documentation of squamous carcinoma of the esophagus at Xijing Hospital.
2. Newly diagnosed Patients with localized carcinoma of the esophagus who have undergone standard testing and been evaluated by the multidisciplinary team at Xijing Hospital and are considered appropriate candidates for and are willing to undergo chemoradiotherapy followed by surgery at Xijing Hospital.
3. Patient must have undergone a baseline esophageal-gastroduodenoscopy (EGD) with biopsy and endoscopic ultrasonography at Xijing, with tissue available for biomarker analysis.
4. Patient must be willing to undergo this research and must provide written informed consent.
Exclusion Criteria:
1. Patient is unable or unwilling to comply with the requirements of the protocol.
2. History of prior malignancy within the past 3 years.
3. Patients with second primary tumors.
4. Patients who received endoscopical therapy or induction chemotherapy prior to chemoradiation therapy are excluded.
5. Patient is not a candidate for chemoradiation followed by surgery.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03029793
Study Brief:
Protocol Section:
NCT03029793